Sort by
Refine Your Search
-
Listed
-
Employer
-
Field
-
Systems.”Funded through an ETH Zurich Career Seed Award, this project aims to develop scientific machine learning frameworks that integrate physics-based modeling with neural network architectures. The goal
-
, you process collected data, prepare reports, and deliver results back to customers and internal teams - ensuring that every project is both professionally executed and well-documented. Further, you will
-
The Institute of Molecular Systems Biology (IMSB) at ETH Zurich invites applications for a Postdoctoral Researcher in Metabolomics & Technology Development in the laboratory of Prof. Dr. Nicola
-
With a service-oriented and improvement-driven mindset, you and the team will contribute to the continuous development of innovative, data-driven approaches and projects in the context of open data and
-
. Roman Zweifel) and CzechGlobe on Innovative technologies cross scales to disentangle carbon dioxide and evapotranspiration fluxes of forests (INETFLUX ). We aim to develop and validate new approaches
-
for the suppliers? R7: How is the market/security impacted by the failure of a large nuclear power plant? This work will be performed using currently developed or in-development tools at RRE. Namely, Euroem , a
-
80%-100%, Zurich, fixed-term The Swiss National Supercomputing Centre (CSCS) develops and operates a high-performance computing and data research infrastructure that supports world-class science in
-
joint disease. Our overarching goal is to identify and target novel molecular mechanisms underlying inflammation and tissue degeneration, with the long-term objective of developing novel disease-modifying
-
100%, Basel, fixed-term We develop technologies to exploit whole cell and enzyme catalysts for manufacturing of substances for applications in fields such as sustainable chemistry, innovative food
-
generations to come. Join Roche, where every voice matters. The Position In Roche’s Pharmaceutical Research and Early Development organization (pRED), we make transformative medicines for patients in order to